KCNE1 (P15382) variants and mutations
KCNE1 (also known as P15382) is a human protein-coding gene encoding a potassium voltage-gated channel subfamily E member 1 protein. An accessory subunit of the KCNQ1 potassium channel that helps regulate cardiac repolarization and inner-ear function. Biallelic pathogenic variants cause Jervell and Lange-Nielsen syndrome type 2, while some variants increase susceptibility to QT prolongation. This analysis covers 459 KCNE1 variants and mutations. Of these, 100% have computational variant effect predictions. Disease context includes long QT syndrome 5, Jervell and Lange-Nielsen syndrome 2, and Jervell and Lange-Nielsen syndrome. Example KCNE1 variants include M1L, I2F, and I2N.
Variant analysis overview
- Gene: KCNE1
- Protein: P15382
- UniProt accession: P15382
- Organism: Homo sapiens
- Variants analyzed: 459
- Variant scope: all variants
- Completed: 2026-10-09
Variant and mutation evidence
- Variant composition: 230 unspecified-consequence records; 89 synonymous variants; 22 frameshift variants; 113 missense variants; 9 stop-gained variants; 2 substitution
- Prediction scores: 457 variants have prediction scores (100% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: long QT syndrome 5, Jervell and Lange-Nielsen syndrome 2, Jervell and Lange-Nielsen syndrome, familial long QT syndrome, Prolonged QT interval, Abnormality of the cardiovascular system, Jervell and Lange-Nielsen syndrome 1, sensorineural hearing loss disorder, autoimmune disorder of central nervous system, neurodegenerative disease, dilated cardiomyopathy, Rare genetic deafness.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 4 post-translational modification sites.
- Structural context: 88 variants have structural context.
- PTM context: 12 variants overlap post-translational modification sites.
- Experimental data: 126 protein positions have experimental scores. Source: trafficking assays, MAVE assays.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Diseases linked to KCNE1
Notable KCNE1 variants
Examples include M1L, I2F, I2N, L3M, L3P, L3L, S4A, N5*. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1L (p.Met1Leu), rs2123460074, ClinGen CA410198669, ClinVar RCV001376771, ClinVar RCV004779113, ESM-1b 0.00, AlphaMissense 0.21, Pathogenic, Long QT syndrome
- I2F (p.Ile2Phe), rs756727116, ClinGen CA320425583, ClinVar RCV000800190, ClinVar RCV004702428, REVEL 0.36, ESM-1b 0.00, Uncertain significance, Cardiovascular phenotype; not provided; Long QT syndrome
- I2N (p.Ile2Asn), ESP rs369808496, ExAC rs369808496, gnomAD rs369808496, REVEL 0.47, ESM-1b 0.00
- L3M (p.Leu3Met), cosmic curated COSV10967, ESM-1b 0.00, AlphaMissense 0.12
- L3P (p.Leu3Pro), rs567021150, ClinGen CA16609059, ClinVar RCV000434020, ClinVar RCV001497881, REVEL 0.44, ESM-1b 0.00, Likely benign, Cardiovascular phenotype; not specified; Long QT syndrome
- L3L (p.Leu3Leu), rs868666103, gnomAD 21-34449626-C-T, CADD 4.07
- S4A (p.Ser4Ala), gnomAD 21-34449625-A-C, REVEL 0.31, ESM-1b 0.00
- N5* (p.Asn5Ter), rs1131691762, ClinGen CA645369791, ClinVar RCV000493904, ClinVar RCV000694374, CADD 24.30, Pathogenic
- N5K (p.Asn5Lys), ExAC rs762400333, gnomAD rs762400333, REVEL 0.45, ESM-1b 0.00
- N5N (p.Asn5Asn), gnomAD 21-34449620-G-A, CADD 0.31
- T6T (p.Thr6Thr), gnomAD 21-34449617-G-T, CADD 4.15
- T6N (p.Thr6Asn), gnomAD 21-34449618-G-T, REVEL 0.23, ESM-1b 0.00
- T7I (p.Thr7Ile), rs28933384, ClinGen CA256863, ClinVar RCV000014418, ClinVar RCV000119076, ESM-1b 0.31, AlphaMissense 0.53, Pathogenic, Jervell and Lange-Nielsen syndrome 2
- T7T (p.Thr7Thr), gnomAD 21-34449614-T-C, CADD 0.46
- A8E (p.Ala8Glu), ESP rs199473348, ExAC rs199473348, gnomAD rs199473348, REVEL 0.56, ESM-1b 0.00, Uncertain significance, in LQT5
- A8S (p.Ala8Ser), rs2516765228, ClinGen CA410198628, ClinVar RCV003053606, ClinVar RCV004779405, ESM-1b 0.00, AlphaMissense 0.09, Uncertain significance, Long QT syndrome
- A8V (p.Ala8Val), rs199473348, ClinGen CA211446, cosmic curated COSV61607, ClinVar RCV000119082, REVEL 0.53, ESM-1b 0.00, Uncertain significance, Cardiovascular phenotype; not specified; Long QT syndrome 5
- A8A (p.Ala8Ala), rs144094344, gnomAD 21-34449611-C-T, CADD 0.54
- V9A (p.Val9Ala), cosmic curated COSV10816, REVEL 0.33, ESM-1b 0.00
- V9M (p.Val9Met), TOPMed rs1423096973, gnomAD rs1423096973, REVEL 0.29, ESM-1b 0.00, Uncertain significance, Long QT syndrome
- T10M (p.Thr10Met), rs144917638, ClinGen CA211441, ClinVar RCV000119089, ClinVar RCV000148515, REVEL 0.50, ESM-1b 0.00, Conflicting interpretations, Cardiovascular phenotype; not specified; not provided
- T10T (p.Thr10Thr), rs187686559, gnomAD 21-34449605-C-A, CADD 1.10
- T10K (p.Thr10Lys), gnomAD 21-34449606-G-T, REVEL 0.41, ESM-1b 0.00
- P11L (p.Pro11Leu), cosmic curated COSV61606, ExAC rs771981567, gnomAD rs771981567, REVEL 0.44, ESM-1b 0.00, Uncertain significance
- P11R (p.Pro11Arg), rs771981567, ClinGen CA16616263, ClinVar RCV000461187, ClinVar RCV003114583, REVEL 0.56, ESM-1b 0.00, Uncertain significance, Long QT syndrome; not provided
- P11S (p.Pro11Ser), ExAC rs775325455, gnomAD rs775325455, REVEL 0.45, ESM-1b 0.00, Uncertain significance
- P11T (p.Pro11Thr), rs775325455, ClinGen CA410198615, ClinVar RCV001315355, ClinVar RCV004779060, REVEL 0.55, ESM-1b 0.00, Uncertain significance, Long QT syndrome
- P11A (p.Pro11Ala), rs1981025573, gnomAD 21-34449516-CCGTC, CADD 26.80
- P11P (p.Pro11Pro), gnomAD 21-34449602-G-T, CADD 6.22
- F12C (p.Phe12Cys), Ensembl rs929395747, REVEL 0.54, ESM-1b 0.00
- L13* (p.Leu13Ter), cosmic curated COSV61607
- L13M (p.Leu13Met), cosmic curated COSV10049, ESM-1b 0.00, AlphaMissense 0.16
- L13V (p.Leu13Val), Ensembl rs919327457, ESM-1b 0.00, AlphaMissense 0.13, Likely benign
- L13L (p.Leu13Leu), gnomAD 21-34449596-C-A, CADD 8.99
- T14S (p.Thr14Ser), Ensembl rs966213112, REVEL 0.16, ESM-1b 0.00
- T14T (p.Thr14Thr), gnomAD 21-34449593-G-T, CADD 6.58
- T14N (p.Thr14Asn), gnomAD 21-34449594-G-T, REVEL 0.16, ESM-1b 0.00
- T14A (p.Thr14Ala), gnomAD 21-34449595-T-C, REVEL 0.16, ESM-1b 0.00
- K15E (p.Lys15Glu), rs2516765058, ClinGen CA410198595, ClinVar RCV003072639, ClinVar RCV004779428, REVEL 0.30, ESM-1b 0.00, Uncertain significance, Long QT syndrome
- K15Q (p.Lys15Gln), rs2516765058, ClinGen CA410198596, ClinVar RCV004522760, ClinVar RCV004780726, ESM-1b 0.00, AlphaMissense 0.08, Uncertain significance, Cardiovascular phenotype
- K15N (p.Lys15Asn), gnomAD 21-34449590-C-A, REVEL 0.21, ESM-1b 0.00
- K15M (p.Lys15Met), gnomAD 21-34449591-T-A, REVEL 0.43, ESM-1b 0.00
- K15R (p.Lys15Arg), gnomAD 21-34449591-T-C, REVEL 0.28, ESM-1b 0.00
- L16M (p.Leu16Met), ExAC rs745951012, gnomAD rs745951012, REVEL 0.44, ESM-1b 0.00
- L16P (p.Leu16Pro), Ensembl rs1981057774, REVEL 0.90, ESM-1b 0.00
- L16L (p.Leu16Leu), gnomAD 21-34449587-C-T, CADD 10.30
- W17* (p.Trp17Ter), rs1244688796, ClinGen CA410198579, cosmic curated COSV10590, ClinVar RCV000659249, CADD 34.00, Pathogenic
- W17R (p.Trp17Arg), rs1469858578, ClinGen CA410198582, ClinVar RCV003648301, ClinVar RCV004780612, REVEL 0.69, ESM-1b 0.00, Uncertain significance, Long QT syndrome
- W17C (p.Trp17Cys), gnomAD 21-34449583-GC-G, CADD 25.70
- Q18K (p.Gln18Lys), gnomAD rs1320384972, REVEL 0.61, ESM-1b 0.00
- Q18Q (p.Gln18Gln), rs149875299, gnomAD 21-34449581-C-T, CADD 9.48
- Q18R (p.Gln18Arg), gnomAD 21-34449582-T-C, REVEL 0.53, ESM-1b 0.00
- Q18* (p.Gln18Ter), gnomAD 21-34449583-G-A, CADD 35.00
- E19K (p.Glu19Lys), 1000Genomes rs183412632, ExAC rs183412632, gnomAD rs183412632, REVEL 0.33, ESM-1b 0.00
- E19D (p.Glu19Asp), gnomAD 21-34449578-C-A, REVEL 0.25, ESM-1b 0.00
- E19G (p.Glu19Gly), gnomAD 21-34449579-T-C, REVEL 0.31, ESM-1b 0.00
- E19Q (p.Glu19Gln), gnomAD 21-34449580-C-G, REVEL 0.27, ESM-1b 0.00
- T20A (p.Thr20Ala), Ensembl rs1981052366, REVEL 0.45, ESM-1b 0.00
- T20I (p.Thr20Ile), rs199473349, ClinGen CA331968, ClinVar RCV000119093, ClinVar RCV004777597, REVEL 0.58, ESM-1b 0.00, Uncertain significance, not provided
- T20T (p.Thr20Thr), gnomAD 21-34449575-T-A, CADD 0.99
- T20K (p.Thr20Lys), gnomAD 21-34449576-G-T, REVEL 0.57, ESM-1b 0.00
- T20S (p.Thr20Ser), gnomAD 21-34449577-T-A, REVEL 0.42, ESM-1b 0.00
- V21I (p.Val21Ile), rs1308048353, ClinGen CA410198554, ClinVar RCV004522761, ClinVar RCV004780727, REVEL 0.26, ESM-1b 0.00, Conflicting interpretations, Long QT syndrome; Cardiovascular phenotype; Long QT syndrome 5
- V21A (p.Val21Ala), gnomAD 21-34449573-A-G, REVEL 0.31, ESM-1b 0.00
- V21F (p.Val21Phe), gnomAD 21-34449574-C-A, REVEL 0.48, ESM-1b 0.00
- Q22H (p.Gln22His), rs1473555254, ClinGen CA410198543, ClinVar RCV002367157, ClinVar RCV004779314, REVEL 0.30, ESM-1b 0.00, Uncertain significance, Cardiovascular phenotype
- Q22Q (p.Gln22Gln), gnomAD 21-34449569-C-T, CADD 0.21
- Q22R (p.Gln22Arg), gnomAD 21-34449570-T-C, REVEL 0.33, ESM-1b 0.00
- Q22* (p.Gln22Ter), gnomAD 21-34449571-G-A, CADD 27.20
- Q22K (p.Gln22Lys), gnomAD 21-34449571-G-T, REVEL 0.32, ESM-1b 0.00
- Q23K (p.Gln23Lys), cosmic curated COSV10742, REVEL 0.35, ESM-1b 0.00
- Q23L (p.Gln23Leu), ExAC rs778331220, gnomAD rs778331220, REVEL 0.51, ESM-1b 0.00
- Q23R (p.Gln23Arg), cosmic curated COSV10590, REVEL 0.37, ESM-1b 0.00
- Q23H (p.Gln23His), gnomAD 21-34449566-C-A, REVEL 0.41, ESM-1b 0.00
- Q23* (p.Gln23Ter), gnomAD 21-34449568-G-A, CADD 31.00
- G24D (p.Gly24Asp), ExAC rs756569224, gnomAD rs756569224, REVEL 0.34, ESM-1b 0.00, Uncertain significance, not provided
- G24G (p.Gly24Gly), gnomAD 21-34449563-A-C, CADD 2.83
- G24V (p.Gly24Val), gnomAD 21-34449564-C-A, REVEL 0.53, ESM-1b 0.00
- G24C (p.Gly24Cys), gnomAD 21-34449565-C-A, REVEL 0.53, ESM-1b 0.00
- G24S (p.Gly24Ser), gnomAD 21-34449565-C-T, REVEL 0.28, ESM-1b 0.00
- G25V (p.Gly25Val), rs2516764848, ClinGen CA410198526, ClinVar RCV003064627, ClinVar RCV004779416, REVEL 0.54, ESM-1b 0.00, Uncertain significance, Long QT syndrome
- G25A (p.Gly25Ala), gnomAD 21-34449560-GC-G, CADD 19.60
- G25G (p.Gly25Gly), rs753064398, gnomAD 21-34449560-G-T, CADD 6.28
- G25D (p.Gly25Asp), gnomAD 21-34449561-C-T, REVEL 0.36, ESM-1b 0.00
- G25C (p.Gly25Cys), gnomAD 21-34449562-C-A, REVEL 0.45, ESM-1b 0.00
- N26N (p.Asn26Asn), rs201604169, gnomAD 21-34449557-G-A, CADD 1.60
- N26K (p.Asn26Lys), gnomAD 21-34449557-G-C, REVEL 0.41, ESM-1b 0.00
- N26T (p.Asn26Thr), gnomAD 21-34449558-T-G, REVEL 0.26, ESM-1b 0.00
- M27T (p.Met27Thr), rs749957298, ClinGen CA320425503, ClinVar RCV001365642, ClinVar RCV002504601, REVEL 0.33, ESM-1b 0.00, Uncertain significance, Jervell and Lange-Nielsen syndrome 2; Long QT syndrome 5; Long QT syndrome
- M27V (p.Met27Val), rs755452452, ClinGen CA320425506, ClinVar RCV001367561, ClinVar RCV004779102, ESM-1b 0.00, AlphaMissense 0.05, Uncertain significance, Long QT syndrome
- M27I (p.Met27Ile), gnomAD 21-34449554-C-T, REVEL 0.28, ESM-1b 0.00
- M27R (p.Met27Arg), gnomAD 21-34449555-A-C, REVEL 0.39, ESM-1b 0.00
- S28L (p.Ser28Leu), rs199473350, ClinGen CA331973, NCI-TCGA Cosmic COSV6160, cosmic curated COSV61606, REVEL 0.61, ESM-1b 0.00, Uncertain significance, KCNE1-related disorder; Cardiovascular phenotype; not provided
- S28W (p.Ser28Trp), gnomAD 21-34449550-CCG-C, CADD 23.00
- S28S (p.Ser28Ser), rs17173510, gnomAD 21-34449551-C-T, CADD 0.18
- S28* (p.Ser28Ter), gnomAD 21-34449552-G-T, CADD 32.00
- G29D (p.Gly29Asp), rs1555844239, ClinGen CA410198499, NCI-TCGA Cosmic COSV6160, cosmic curated COSV61607, REVEL 0.35, ESM-1b 0.00, Uncertain significance, not provided
- G29G (p.Gly29Gly), rs1177001886, gnomAD 21-34449548-G-A, CADD 10.20
- G29S (p.Gly29Ser), gnomAD 21-34449550-C-T, REVEL 0.39, ESM-1b 0.00
- L30L (p.Leu30Leu), gnomAD 21-34449545-C-A, CADD 9.13
- L30R (p.Leu30Arg), gnomAD 21-34449546-A-C, REVEL 0.57, ESM-1b 0.00
- L30P (p.Leu30Pro), gnomAD 21-34449546-A-G, REVEL 0.38, ESM-1b 0.00
- L30V (p.Leu30Val), gnomAD 21-34449547-G-C, REVEL 0.48, ESM-1b 0.00
- A31S (p.Ala31Ser), cosmic curated COSV61607, REVEL 0.56, ESM-1b 0.00
- A31T (p.Ala31Thr), rs753462079, ClinGen CA320425498, ClinVar RCV002371240, ClinVar RCV004721061, REVEL 0.50, ESM-1b 0.00, Uncertain significance, Cardiovascular phenotype; Long QT syndrome; not provided
- A31V (p.Ala31Val), rs532752739, ClinGen CA320425496, ClinVar RCV003533805, ClinVar RCV004101679, REVEL 0.46, ESM-1b 0.00, Uncertain significance, Cardiovascular phenotype; Long QT syndrome
- A31A (p.Ala31Ala), gnomAD 21-34449542-G-T, CADD 10.10
- A31D (p.Ala31Asp), gnomAD 21-34449543-G-T, REVEL 0.60, ESM-1b 0.00
- R32C (p.Arg32Cys), rs200963514, ClinGen CA236728, cosmic curated COSV61606, ClinVar RCV000171659, REVEL 0.78, ESM-1b 0.18, Uncertain significance, Cardiovascular phenotype; not provided; Long QT syndrome
- R32H (p.Arg32His), rs17857111, ClinGen CA331978, cosmic curated COSV61606, ClinVar RCV000119095, REVEL 0.39, ESM-1b 0.00, Uncertain significance, Cardiovascular phenotype; not specified; Long QT syndrome 5
- R32R (p.Arg32Arg), gnomAD 21-34449539-G-T, CADD 6.84
- R32L (p.Arg32Leu), gnomAD 21-34449540-C-A, REVEL 0.41, ESM-1b 0.00
- R32P (p.Arg32Pro), gnomAD 21-34449540-C-G, REVEL 0.51, ESM-1b 0.00
- R32S (p.Arg32Ser), gnomAD 21-34449541-G-T, REVEL 0.51, ESM-1b 0.00
- R33G (p.Arg33Gly), rs2516764659, ClinGen CA410198485, ClinVar RCV003648462, ClinVar RCV004780617, REVEL 0.60, ESM-1b 0.00, Uncertain significance, Long QT syndrome
- R33M (p.Arg33Met), Ensembl rs1981037805, REVEL 0.53, ESM-1b 0.00
- R33S (p.Arg33Ser), rs771964597, ClinGen CA320425490, ClinVar RCV003876038, ClinVar RCV004369589, REVEL 0.36, ESM-1b 0.00, Uncertain significance, Long QT syndrome; Cardiovascular phenotype
- R33W (p.Arg33Trp), gnomAD 21-34449538-T-A, REVEL 0.55, ESM-1b 0.00
- S34A (p.Ser34Ala), ESP rs376479233, ExAC rs376479233, gnomAD rs376479233, REVEL 0.20, ESM-1b 0.00
- S34P (p.Ser34Pro), ESP rs376479233, ExAC rs376479233, gnomAD rs376479233, REVEL 0.40, ESM-1b 0.00, Uncertain significance, not provided
- S34T (p.Ser34Thr), ESP rs376479233, ExAC rs376479233, gnomAD rs376479233, ESM-1b 0.00, AlphaMissense 0.09, Uncertain significance, Long QT syndrome
- S34Y (p.Ser34Tyr), ExAC rs774614463, gnomAD rs774614463, REVEL 0.43, ESM-1b 0.00
- S34S (p.Ser34Ser), rs1555844211, gnomAD 21-34449533-G-A, CADD 1.78
- S34F (p.Ser34Phe), rs774614463, gnomAD 21-34449534-G-A, REVEL 0.27, ESM-1b 0.00
- S34C (p.Ser34Cys), gnomAD 21-34449534-G-C, REVEL 0.28, ESM-1b 0.00
- P35L (p.Pro35Leu), rs2516764586, ClinGen CA410198471, ClinVar RCV003835856, ClinVar RCV004780671, ESM-1b 0.00, AlphaMissense 0.09, Uncertain significance, Long QT syndrome
- P35S (p.Pro35Ser), rs771113232, ClinGen CA320425483, ClinVar RCV003648793, ClinVar RCV004780629, REVEL 0.32, ESM-1b 0.00, Uncertain significance, Long QT syndrome; not provided
- P35P (p.Pro35Pro), rs1237489472, gnomAD 21-34449530-G-A, CADD 0.92
- P35H (p.Pro35His), gnomAD 21-34449531-G-T, REVEL 0.34, ESM-1b 0.00
- R36C (p.Arg36Cys), rs372398235, ClinGen CA320425481, cosmic curated COSV10049, ClinVar RCV000619059, REVEL 0.50, ESM-1b 0.00, Conflicting interpretations, Cardiovascular phenotype; not provided; Long QT syndrome
- R36G (p.Arg36Gly), rs372398235, ClinGen CA320425480, ClinVar RCV001931289, ClinVar RCV004779205, ESM-1b 0.00, AlphaMissense 0.06, Conflicting interpretations, Long QT syndrome; Cardiovascular phenotype
- R36H (p.Arg36His), rs199473351, ClinGen CA331911, cosmic curated COSV61607, ClinVar RCV000119062, REVEL 0.50, ESM-1b 0.00, Conflicting interpretations, KCNE1-related disorder; Cardiovascular phenotype; not specified
- R36R (p.Arg36Arg), rs200187147, gnomAD 21-34449527-G-C, CADD 4.83
- R36A (p.Arg36Ala), rs1568836956, gnomAD 21-34449528-CG-C, CADD 12.40
- R36L (p.Arg36Leu), gnomAD 21-34449528-C-A, REVEL 0.33, ESM-1b 0.00
- R36P (p.Arg36Pro), gnomAD 21-34449528-C-CG, CADD 17.80
- R36S (p.Arg36Ser), gnomAD 21-34449529-G-T, REVEL 0.39, ESM-1b 0.00
- S37G (p.Ser37Gly), rs886044294, ClinGen CA10606580, ClinVar RCV000383746, ClinVar RCV001850457, REVEL 0.33, ESM-1b 0.00, Uncertain significance, not provided; Long QT syndrome 5; Jervell and Lange-Nielsen syndrome 2
- S37N (p.Ser37Asn), rs1290531137, ClinGen CA410198465, cosmic curated COSV61606, ClinVar RCV000823043, ESM-1b 0.00, AlphaMissense 0.07, Uncertain significance, Long QT syndrome
- S37T (p.Ser37Thr), rs1290531137, ClinGen CA410198464, ClinVar RCV001983242, ClinVar RCV004779225, REVEL 0.23, ESM-1b 0.00, Uncertain significance, Long QT syndrome; not provided
- S37R (p.Ser37Arg), gnomAD 21-34449523-TG-T, CADD 0.00
- S37S (p.Ser37Ser), rs150458884, gnomAD 21-34449524-G-A, CADD 0.13
- S37I (p.Ser37Ile), gnomAD 21-34449525-C-A, REVEL 0.29, ESM-1b 0.00
- S38D (p.Ser38Asp), rs1064795410, ClinGen CA16620989, ClinVar RCV000478086, ClinVar RCV003278832, ESM-1b 0.00, AlphaMissense 0.06, Conflicting interpretations, Cardiovascular phenotype; KCNE1-related disorder; not specified
- S38G (p.Ser38Gly), rs1805127, ClinGen CA131330, cosmic curated COSV61606, ClinVar RCV000035351, REVEL 0.28, ESM-1b 0.00, Benign/Likely benign, Cardiovascular phenotype; not provided; Long QT syndrome 5
- S38N (p.Ser38Asn), rs1057522990, ClinGen CA16608493, ClinVar RCV000427530, ClinVar RCV004022427, REVEL 0.26, ESM-1b 0.00, Conflicting interpretations, Cardiovascular phenotype; not specified
- S38R (p.Ser38Arg), 1000Genomes rs1805127, ESP rs1805127, ExAC rs1805127, gnomAD rs1805127, REVEL 0.32, ESM-1b 0.00, Uncertain significance, not provided
- S38S (p.Ser38Ser), gnomAD 21-34449521-A-G, CADD 0.47
- S38C (p.Ser38Cys), gnomAD 21-34449523-T-A, REVEL 0.29, ESM-1b 0.00
- D39N (p.Asp39Asn), rs199473352, ClinGen CA231692, ClinVar RCV000119064, ClinVar RCV004777577, ESM-1b 0.00, AlphaMissense 0.08, not provided
- D39E (p.Asp39Glu), gnomAD 21-34449516-CCG-C, CADD 18.30
- D39D (p.Asp39Asp), rs368465967, gnomAD 21-34449518-G-A, CADD 2.21
- G40S (p.Gly40Ser), rs778439872, ClinGen CA320425458, ClinVar RCV000631757, ClinVar RCV001461605, REVEL 0.26, ESM-1b 0.00, Conflicting interpretations, not provided; Cardiovascular phenotype; Long QT syndrome
- G40V (p.Gly40Val), Ensembl rs2123458875, REVEL 0.38, ESM-1b 0.00
- G40G (p.Gly40Gly), gnomAD 21-34449515-G-T, CADD 4.11
- G40D (p.Gly40Asp), gnomAD 21-34449516-C-T, REVEL 0.21, ESM-1b 0.00
- G40C (p.Gly40Cys), gnomAD 21-34449517-C-A, REVEL 0.51, ESM-1b 1.00
- K41N (p.Lys41Asn), rs763754260, ClinGen CA10583883, ClinVar RCV000230619, ClinVar RCV000620863, REVEL 0.19, ESM-1b 0.00, Uncertain significance, Cardiovascular phenotype; Long QT syndrome
- L42L (p.Leu42Leu), gnomAD 21-34449509-C-T, CADD 8.48
- L42Q (p.Leu42Gln), gnomAD 21-34449510-A-T, REVEL 0.69, ESM-1b 0.00
- L42M (p.Leu42Met), gnomAD 21-34449511-G-T, REVEL 0.46, ESM-1b 0.00
- E43D (p.Glu43Asp), cosmic curated COSV61606, REVEL 0.60, ESM-1b 0.00
- E43G (p.Glu43Gly), Ensembl rs1981021182, REVEL 0.65, ESM-1b 0.00
- E43K (p.Glu43Lys), rs755781709, ClinGen CA16616501, ClinVar RCV000477286, ClinVar RCV000852544, REVEL 0.68, ESM-1b 0.00, Uncertain significance, Cardiovascular phenotype; not provided; Arrhythmogenic right ventricular cardiom
- E43E (p.Glu43Glu), rs560251161, gnomAD 21-34449506-C-T, CADD 5.52
- E43* (p.Glu43Ter), gnomAD 21-34449508-C-A, CADD 34.00
- A44T (p.Ala44Thr), ExAC rs767315445, gnomAD rs767315445, ESM-1b 0.00, AlphaMissense 0.14
- A44A (p.Ala44Ala), gnomAD 21-34449503-G-T, CADD 2.04
- A44D (p.Ala44Asp), gnomAD 21-34449504-G-T, REVEL 0.55, ESM-1b 0.00
- A44P (p.Ala44Pro), gnomAD 21-34449504-GC-G, CADD 24.90
- A44S (p.Ala44Ser), gnomAD 21-34449505-C-A, REVEL 0.44, ESM-1b 0.00
- L45L (p.Leu45Leu), gnomAD 21-34449500-G-A, CADD 9.93
- L45P (p.Leu45Pro), gnomAD 21-34449501-A-AG, CADD 32.00
- Y46* (p.Tyr46Ter), rs758346045, ClinGen CA320425430, ClinVar RCV000659247, ClinVar RCV004777810, CADD 33.00, Pathogenic
- Y46C (p.Tyr46Cys), rs1402178514, ClinGen CA410198408, ClinVar RCV000612549, ClinVar RCV000786138, REVEL 0.78, ESM-1b 1.00, Conflicting interpretations, Rare genetic deafness; Cardiovascular phenotype; not provided
- Y46Y (p.Tyr46Tyr), rs758346045, gnomAD 21-34449497-G-A, CADD 8.04
- V47A (p.Val47Ala), rs2516764256, ClinGen CA410198403, ClinVar RCV002389479, ClinVar RCV004779326, ESM-1b 0.00, AlphaMissense 0.70, Uncertain significance, Cardiovascular phenotype
- V47D (p.Val47Asp), rs2516764256, ClinGen CA410198404, ClinVar RCV004520792, ClinVar RCV004780722, REVEL 0.82, ESM-1b 1.00, Uncertain significance, Cardiovascular phenotype
- V47F (p.Val47Phe), rs199473353, ClinGen CA331916, ClinVar RCV000119065, ClinVar RCV004777578, ESM-1b 0.00, AlphaMissense 0.07, not provided, Congenital long QT syndrome
- V47I (p.Val47Ile), rs199473353, ClinGen CA320425428, cosmic curated COSV61607, ClinVar RCV000631784, REVEL 0.39, ESM-1b 0.00, Conflicting interpretations, Cardiovascular phenotype; not specified; not provided
Public KCNE1 analysis runs
- KCNE1 analysis run — KCNE1 (459 variants) — completed 2026-10-09